The rise and fall of malignant fibrous histiocytoma

Ultrastructural Pathology

Volumn 28, Issue 5-6, 2004, Pages 283-289

  Erlandson, Robert A ^a   Antonescu, Cristina R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Classification; Immunohistochemistry; Malignant fibrous histiocytoma; Pleomorphic fibrosarcoma; Ultrastructure

Indexed keywords

CANCER DIAGNOSIS; CELL DIFFERENTIATION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT FIBROUS HISTIOCYTOMA; PHENOTYPE; PRIORITY JOURNAL; SOFT TISSUE TUMOR; ULTRASTRUCTURE;

FIBROBLASTS; FIBROSARCOMA; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; SOFT TISSUE NEOPLASMS; TERMINOLOGY;

EID: 10644258722     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.1080/019131290882150     Document Type: Conference Paper

References (78)

1. Lattes R. Surgical pathology at the College of Physicians and Surgeons of Columbia University. In: Rosai J, ed. Guiding the Surgeon's Hand: The History of Modern Surgical Pathology. Washington, DC: American Registry of Pathology, AFIP; 1997:41-60.
2. Ozzello L, Stout AP, Murray MR. Cultured characteristics of malignant histiocytomas and fibrous xanthomas. Cancer. 1963;16:331-344.
3. O'Brian JE, Stout AP. Malignant fibrous xanthomas. Cancer. 1964;17:1446-1455.
4. Kempson RL, Kyriakos M. Fibroxanthosarcoma of soft tissues: a subtype of malignant fibrous histiocytoma. Cancer. 1972;29:961-976.
5. Stout AP, Lattes R. Tumors of soft tissues. In: Atlas of Tumor Pathology, 2nd Series, Fascicle 1. Washington, DC: AFIP; 1967:32-52.
6. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: a analysis of 200 cases. Cancer. 1978;41:2250-2266.
7. Kearny MM, Soule E, Ivins JC. Malignant fibrous histiocytoma: a retrospective study of 167 cases. Cancer. 1980;45:167-178.
8. Enjoji M, Hashimoto H, Tsuneyoshi M, Iwaski H. Malignant fibrous histiocytoma: a clinicopathological study of 130 cases. Acta Pathol Jpn. 1980;30:727-741.
9. Weiss SW. Malignant fibrous histiocytoma: a reaffirmation. Am J Surg Pathol. 1982;6:773-784.
10. Enzinger F. Recent developments in the classification of soft tissue sarcomas. In: Management of Primary Bone and Soft Tissue Sarcomas. Chicago: Year Book of Medical Publishers; 1977.
11. Enzinger FM, Weiss SW. Soft Tissue Tumors. St. Louis: CV Mosby; 1983:166-198.
12. Leak LV, Caufield JB, Burke JF, et al. Electron microscopic studies on a human myxofibrosarcoma. Cancer Res. 1967;27:261-285.
13. Kindblom L-G, Merck C, Angervall L. The ultrastructure of myxofibrosarcomas: a study of 11 cases. Virchows Arch A. 1979;381:121-139.
14. Waters BL, Panagopoulos I, Allen EF. Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11. Cancer Genet Cytogenet. 2000;121:109-116.
15. Taxy JB, Battifora H. Malignant fibrous histiocytoma: an electron microscopic study. Cancer. 1977;40:254-267.
16. Alguacil-Garcia A, Unni KK, Goellner JR. Malignant fibrous histiocytoma: an ultrastructural study of six cases. Am J Clin Pathol. 1978;69:121-129.
17. Merkow LP, Frick JC, Shifkin M, Kreages CG, Parde M. Ultrastructure of fibroxanthosarcoma (malignant fibroxanthoma). Cancer. 1971;28:372-383.
18. Limacher J, Delage C, Lagace R. Malignant fibrous histiocytoma. Clinicopathological and ultrastructural study of 12 cases. Am J Surg Pathol. 1978;2:265-274.
19. Harris M. The ultrastructure of benign and malignant fibrous histiocytomas. Histopathology. 1980;4:29-44.
20. Fukuda T, Tsuneyoshi M, Enjoji M. Malignant fibrous histiocytoma of soft parts: an ultrastructural quantitative study. Ultrastruct Pathol. 1998;12:117-129.
21. Lagacé R. The ultrastructural spectrum of malignant fibrous histiocytoma. Ultrastruct Pathol. 1987;11:153-159.
22. Lagacé R, Delage C, Seemayer TA. Myxoid variant of malignant fibrous histiocytoma: ultrastructural observations. Cancer. 1979;43:526-534.
23. Jabi M, Jeans D, Dardick I. Ultrastructural heterogeneity in malignant fibrous histiocytoma of soft tissue. Ultrastruct Pathol. 1987;11:583-592.
24. Tsuneyoshi M, Enjoji M, Shinohara N. Malignant fibrous histiocytoma: an electron microscopic study of 17 cases. Virchows Arch A. 1981;392:135-145.
25. Du Bouley CEH. Demonstration of alpha-1-antitrypsin and alpha-1-antichymotrypsin in fibrous histiocytomas using the immunoperoxidase technique. Am J Surg Pathol. 1982;6:559-564.
26. Soini Y, Miettinen M. Alpha-1-antitrypsin and lysozyme: their limited significance in fibrohistiocytic tumors. Am J Clin Pathol. 1989;91:515-521.
27. Strauchen JA, Dimitriu-Bona A. Malignant fibrous histiocytoma: expression of monocyte/macrophage differentiation antigens detected with monoclonal antibodies. Am J Pathol. 1986;124:303-309.
28. Wood GS, Beckstead JH, Turner RR, Hendrickson MR, Kempson RL, Warnke RA. Malignant fibrous histiocytoma cells resemble fibroblasts. Am J Surg Pathol. 1986;10:323-335.
29. Lawson CW, Fisher C, Gatter KC. An immunohistochemical study of differentiation in malignant fibrous histiocytoma. Histopathology. 1978;11:375-378.
30. Brecker ME, Franklin WA. Absence of mononuclear phagocytic antigens in malignant fibrous histiocytoma. Am J Clin Pathol. 1986;86:344-348.
31. Fu YS, Gabbiani G, Kaye GI, Lattes R. Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytoma): general considerations and electron microscopic and tissue culture studies. Cancer. 1975;35:176-198.
32. Roholl PJM, Kleijne J, van Basten CDH, van der Putten SCJ, van Unnik JAM. A study to analyze the origin of tumor cells in malignant fibrous histiocytoma: a multiparametric characterization. Cancer. 1985;56:2809-2815.
33. Enzinger FM. Malignant fibrous histiocytoma 20 years after Stout. Am J Surg Pathol. 1986;10(suppl):43-53.
34. Genberg M, Mark J, Hakekius L, Ericsson J, Nister M. Origin and relation between different cell types in malignant fibrous histiocytoma. Am J Surg Pathol. 1989;135:1185-1196.
35. Kauffman SL, Stout AP. Histiocytic tumors (fibrous xanthoma and histiocytoma) in children. Cancer. 1961;14:469-482.
36. Hoffman MA, Dickersin GR. Malignant fibrous histiocytoma: an ultrastructural study of 11 cases. Hum Pathol. 1983;14:913-922.
37. Dehner LP. Malignant fibrous histiocytoma. Non specific morphologic pattern, specific pathologic entity, or both? Arch Pathol Lab Med. 1988;112:236-237.
38. Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol. 1992;16:213-228.
39. Hollowood K, Fletcher CDM. Malignant fibrous histiocytoma: morphologic pattern or pathologic entity? Semin Diagn Pathol. 1995;12:210-220.
40. Meister P. Malignant fibrous histiocytoma: histomorphological pattern or tumor type. Pathol Res Pract. 1996;192:887-881.
41. Fletcher CDM. Soft tissue tumors. In: CDM Fletcher, ed. Diagnostic Histopathology of Tumors. New York: Churchill Livingstone; 1995:1066-1072.
42. Erlandson RA, Woodruff JM. Role of electron microscopy in the evaluation of soft tissue neoplasms, with emphasis on spindle cell and pleomorphic tumors. Hum Pathol. 1998;29:1372-1381.
43. Takeya M, Yamashiro S, Yoshimara T, et al. Immunophenotype and immunoelectron microscopy characterization of major constituent cells in malignant fibrous histiocytoma using cell lines and their transplanted tumors in immunodeficient mice. Lab Invest. 1995;72:679-688.
44. Iwaski H, Isayama T, Ohjimi Y, et al. Malignant fibrous histiocytoma: a tumor of facultative histiocytes showing mesenchymal differentiation in cultured cell lines. Cancer. 1992;69:437-447.
45. Erlandson RA. Diagnostic Transmission Electron Microscopy of Tumors: With Clinicopathological, Immunohistochemical, and Cytogenetic Correlations. New York: Raven; 1994:368-373.
46. Hatano H, Tokunaga T, Ogose A, et al. Origin of the histiocytic cells and multinucleated giant cells in malignant fibrous histiocytoma: neoplastic or reactive? Pathol Int. 1999;49:14-22.
47. McHugh M, Miettinen M. KP1 (CD68): its limited specificity for histiocytic tumors. Appl Immunohistochem. 1994;21:186-190.
48. Suh CH, Ordóñez NG, Mackay B. Malignant fibrous histiocytoma: an ultrastructural perspective. Ultrastruct Pathol. 2000;24:243-250.
49. Antonescu CR, Erlandson RA, Huvos AG. Primary fibrosarcoma and malignant fibrous histiocytoma of bone - a comparative ultrastructural study: evidence of a spectrum of fibroblastic differentiation. Ultrastruct Pathol. 2000;24:83-91.
50. Binder SW, Said JW, Shintaku P, et al. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma: use of a monoclonal antibody KP-1(CD68). Am J Clin Pathol. 1992;97:759-763.
51. Weiss LM. Soft Tissues. In: Weidner N, Cote RJ, Suster S, Weiss LM, eds. Modern Surgical Pathology. Philadelphia: Saunders; 2003:1806-1816.
52. Sappino AP, Schürch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as markers of phenotypic modulation. Lab Invest. 1990;63:144-161.
53. Schmitt-Graf A, Desmouliere A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblast cell plasticity. Virchows Arch. 1994;425:3-24.
54. Herrera GA, Johnson WW, Lockard VG, et al. Soft tissue myofibroblastomas. Mod Pathol. 1991;4:571-577.
55. Mentzel T, Fletcher CDM. The emerging role of myofibroblasts in soft tissue neoplasia. Am J Clin Pathol. 1997;107:2-5.
56. Montgomery E, Goldblum JR, Fisher C. Myofibrosarcoma. A clinicopathologic study. Am J Surg Pathol. 2001;25:219-228.
57. Eyden BP, Banerjee SS, Harris M, et al. A study of spindle cell sarcomas showing myofibroblastic differentiation. Ultrastruct Pathol. 1991;15:367-378.
58. Schürch W, Seemayer TA, Gabbiani G. The myofibroblast a quarter century after Its discovery. Am J Surg Pathol. 1998;22:141-147.
59. Montgomery E, Fisher C. Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study. Histopathology. 2001;38:499-509.
60. Hirose T, Sano T, Abe J-I, et al. Malignant fibrous histiocytoma with epithelial differentiation? Ultrastruct Pathol. 1998;12:529-536.
61. Hirose T, Kudo E, Hasegawa T, Abe J, Hizawa K. Expression of intermediate filaments in malignant fibrous histiocytoma. Hum Pathol. 1989;20:871-877.
62. Miettinen M, Soini Y. Malignant fibrous histiocytoma: heterogeneous patterns of intermediate filament proteins by immunohistochemistry. Arch Pathol Lab Med. 1989;113:1363-1366.
63. Roholl PJM, Prinsen I, Rademakers PHM, et al. Two cell lines with epithelial cell-like characteristics established from malignant fibrous histiocytomas. Cancer. 1991;68:1963-1972.
64. Litzkey LA, Brooks JJ. Cytokeratin immunoreactivity in malignant fibrous histiocytoma and spindle cell tumors: comparison between frozen and paraffin-embedded tissues. Mod Pathol. 1992;5:30-34.
65. Rosenberg AE, O'Connell JK, Dickersin GR, Bhan AK. Expression of epithelial markers in malignant fibrous histiocytoma of the musculoskeletal system: an immunohistochemical and electron microscopic study. Hum Pathol. 1993;24:284-293.
66. Weiss SW, Brathauser BA, Morris PA. Postirradiation malignant fibrous histiocytoma expressing cytokeratin: implications for the immunodiagnosis of sarcomas. Am J Surg Pathol. 1988;12:554-448.
67. Antonescu CR, Erlandson RA. Fibrosarcoma mimicking plasmacytoma or carcinoma: an ultrastructural study of 4 cases. Ultrastruct Pathol. 2001;25:31-37.
68. Brooks JJ. The significance of multiphenotypic patterns and markers in human sarcomas: a new model of mesenchyme differentiation. Am J Surg Pathol. 1986;125:113-123.
69. Downes KA, Goldblum JR, Montgomery EA, Fisher C. Pleomorphic liposaroma: a clinicopathological analysis of 19 cases. Mod Pathol. 2001;14:179-184.
70. Oda Y, Miyajima K, Kawaguchi K-I, et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am J Surg Pathol. 2001;25:1030-1038.
71. Gaffney EF, Dervan PA, Fletcher CDM. Pleomorphic rhabdomyosarcoma in adulthood: analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol. 1993;17:601-609.
72. Stout AP. Fibrosarcoma: the malignant tumor of fibroblasts. Cancer. 1948;1:30-63.
73. Hajdu SI. Fibrosarcoma: a historic commentary. Cancer. 1998;82:2081-2089.
74. Meiss JM. "Dedifferentiation" in bone and soft tissue tumors: a histological indicator of tumor progression. Pathol Annu. 1991;26 (pt 1):37-62.
75. Coindre J-M, Mariani O, Chibon F, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocyoma. Mod Pathol. 2003;16:256-262.
76. Henricks WH, Chu YC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposed expanded definition of dedifferentiation. Am J Surg Pathol. 1997;21:271-281.
77. Hirose T, Sano T, Hizawa K. Ultrastructural study of the myxoid area of malignant fibrous histiocytoma. Ultrastruct Pathol. 1997;21:271-281.
78. Mc Cormick D, Mentzel T, Beham A, Fletcher CDM. Dedifferentiated liposarcoma: clinicopathologic analysis of 32 cases suggesting a better prognosis subgroup among pleomorphic sarcomas. Am J Surg Pathol. 1994;18:1213-1223.